Dr. Repovic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 E Jefferson St
Ste A - MS Center
Seattle, WA 98122Phone+1 206-320-2200Fax+1 206-386-2845
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Neuroimmunology & Multiple Sclerosis, 2008 - 2010
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2004 - 2008
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2007
- University of Alabama School of MedicineClass of 2004
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- WA State Medical License 2010 - 2025
- NY State Medical License 2006 - 2011
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 1 citationsMulti-Omic characterization of the effects of Ocrelizumab in patients with relapsing-remitting multiple sclerosis.Sergey A Kornilov, Nathan D Price, Richard Gelinas, Juan Acosta, Mary E Brunkow
Journal of the Neurological Sciences. 2024-12-15 - Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS.Marcus W Koch, Carlos Camara-Lemarroy, Eva Strijbis, Jop Mostert, Victoria M Leavitt
Multiple Sclerosis. 2024-12-01 - People with multiple sclerosis help design a tool to measure physical functioning and how it affects their daily lives: a plain language summary.Paul Kamudoni, Dagmar Amtmann, Jeffrey Johns, Karon F Cook, Rana Salem
Neurodegenerative Disease Management. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: